Dehydration can trigger water retention as the body compensates for fluid deficit, paradoxically stalling weight loss on the scale even as fat continues to decrease
Notable safety advantages : Lower discontinuation rates due to adverse events (4-7%) compared to reported rates with semaglutide 2.4 mg in STEP trials (approximately 6-7%) No signal for diabetic retinopathy worsening (a concern identified with semaglutide in SUSTAIN-6) No evidence of increased psychiatric adverse events (depression, suicidality) Research Applications Tirzepatide serves as a groundbreaking research tool across multiple biomedical domains: Dual incretin biology : Studying the synergistic effects of simultaneous GIP and GLP-1 receptor activation on glucose homeostasis, appetite, and metabolism Adipose tissue biology : Investigating GIPR-mediated effects on adipocyte differentiation, lipid buffering, and adipokine secretion mechanisms absent from GLP-1 agonist research Central appetite neuroscience : Mapping distinct GIP vs
Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation
molecular weight 848.8 g/mol
Starting a prescription-based weight loss journey can feel like a big step
Disturbances of the parasympathetic branch of the autonomic nervous system in patients with gastroesophageal reflux disease (GERD) estimated by short-term heart rate variability recordings
